Joseph R. Stoll

发表

Dermatologic adverse events associated with IDH inhibitors ivosidenib and enasidenib for the treatment of acute myeloid leukemia.

S. Dusza, A. Markova, M. Pulitzer, 2022, Leukemia research.

Real-time Reflectance Confocal Microscopy of Cutaneous Graft-versus-Host Disease Correlates with Histopathology.

S. Dusza, M. Ardigó, J. Monnier, 2021, Transplantation and cellular therapy.

Efficacy of immunotherapy with combination of cryotherapy and topical imiquimod for treatment of Kaposi sarcoma

A. Rossi, C. Lezcano, A. Markova, 2022, Journal of medical virology.

Association of interleukin-6 and tumor necrosis factor-α with mortality in hospitalized patients with cancer

M. Lacouture, S. Dusza, A. Markova, 2020 .

Association of IL-6 and TNF-α with mortality in hospitalized cancer patients.

M. Lacouture, S. Dusza, A. Markova, 2020, Journal of the American Academy of Dermatology.

Primary cutaneous T-cell lymphomas other than Mycosis Fungoides and Sezary Syndrome - Part I: Clinical and histologic features and diagnosis.

S. Horwitz, J. Willner, M. Pulitzer, 2021, Journal of the American Academy of Dermatology.

Article Topic/Title: Primary cutaneous T-cell lymphomas other than Mycosis Fungoides and Sezary Syndrome. Part II: Prognosis and Management.

S. Horwitz, M. Pulitzer, P. Myskowski, 2021, Journal of the American Academy of Dermatology.

Veronica Rotemberg, Ashfaq A Marghoob, Allan C Halpern, 2021, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

Management of immune-related cutaneous adverse events with dupilumab

M. Lacouture, Y. Janjigian, S. Dusza, 2023, Journal for ImmunoTherapy of Cancer.

A Randomized, Double-Blind, Placebo-Controlled, Split-Face Study of the Efficacy of Topical Epidermal Growth Factor for the Treatment of Melasma.

R. Moy, A. Lyons, Joseph R. Stoll, 2018, Journal of drugs in dermatology : JDD.